EPA2024 Budapest, Hungary. 6 -9 April 2024.
Days
Hours
Mins
Secs
0 Days (CLOSED)

Abstracts

Transparent EPA symbol

Abstracts

Late breaking Abstract Submissions are now closed!

Abstracts received after the deadline will not be considered.

Abstracts submitted by email will not be accepted.

Authors will be notified by January 2024

  • Late breaking Abstract Submission deadline: 10 November 2023, 23:59, CET
  • Authors will be notified by January 2024

Travel grants

The EPA offers Travel Grants to help abstract submitters with the cost of attending the Congress. Submit your Travel Grant application along with your abstract! Travel Grants applications for the 32nd European Congress of Psychiatry are open during the abstract submission period. Applications are now closed. 

Rules for submission

Presentation Type: Abstracts may be submitted for Oral Communication Session, e-Poster Presentation or e-Poster Viewing. The Scientific Programme Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.

All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university-specific publications office (or another similar facility) or by a copy editor, prior to submission.

Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced as submitted. No proofreading will be done. It is not possible to modify abstracts after the submission deadline.

The work described in the abstract needs to have an appropriate approval under local, ethical and animal experimentation rules.

Abstracts must be original and must not be or have been published or presented at any other meeting prior to the Congress.

Submissions may not contain patient names, hospital ID numbers or other identifying information.

The inclusion of trade names/brand names is not allowed in the abstract. Please use generic names of drugs. The mentioning of agents/molecules must follow the scientific standard for publications. The presentation must be balanced and contain no commercial promotional content.

Conflict of interest: It is the intent of EPA to provide high quality sessions focused on educational content that is free from commercial influence or bias. Thus the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during the abstract submission.

An abstract can only be submitted if the “Declaration” on the online abstract form is read and accepted.

Please note that each person may submit up to 5 abstracts as a presenting author. Whilst the Organisers will try to avoid scheduling conflicts, these might occur. In this case, one of the listed co-authors needs to take over the presentation.

Submission topics

Abstracts can be submitted in one of 51 topics:

The correct topic must be selected to ensure correct scoring. The content of the abstract must be topic related.  The Committee reserves the right to change the topic under which the abstract was originally submitted.

 

Abstract typing instructions

For standardisation, the acceptable length of the abstract is limited to 3000 characters and 45 lines, with authors’ details, headers and tables included. This also includes non-visible characters such as spaces as well as punctuation.

The abstract should be structured into the following sections:

  • A title which clearly indicates the nature of the investigation
  • Introduction
  • Objectives
  • Methods
  • Results
  • Conclusions

Up to three tables can be included in the Results section with the following criteria:

  • Maximum number of columns: 10
  • Maximum number of rows: 10

Tables count towards the total number of allowed characters and lines.

Up to three images/graphs can be included. They should be of high quality, and lettering/symbols/lines should be clear and distinct. Images will be reduced to one column width.

The system only accepts images that fulfil the following criteria:

  • Image width: min. 50 pixels – max. 600 pixels
  • Image height: min. 50 pixels – max. 800 pixels
  • Image quality: min. 96 dpi – max. 300 dpi
  • Image file size: min. 40 KB – max. 1000 KB
  • Allowed file types: gif, jpg

All tables, figures, and reference citations must be referred to in the text of the abstract. If there is no reference in the text, the table/figure/reference (as applicable) will be removed from the abstract before publication.

If references are essential, they should be within the text, in the form: (Murphy et al. BJU Int 2005; 95 27-30).

Submission system information

Abstracts can be saved in “Draft” status to be re-edited and finalised until the submission deadline. Therefore, the submitter will be required to create a user account.

Abstracts fulfilling all criteria can be saved in “Final submission” status. Only abstracts in “Final submission” status will be regarded as successfully submitted and considered for the congress.

Abstracts in “Final submission” status can be re-edited and modified until the submission deadline.

Abstract review

The abstracts will be reviewed by the Local Organising Committee and an experienced panel of reviewers. Following the information regarding acceptance, scheduling information will be sent to the Abstract Submitter.

Abstract acceptance and publication

Accepted abstracts will be published in an e-supplement of the European Psychiatry Journal and will be made available on the Congress website. 

Only abstracts of authors who have confirmed the presentation and are duly registered by the deadline of 1 March 2024 will be scheduled and included in the Congress Abstract e-Supplement.

The presenters will receive a dedicated email with detailed instructions to confirm their presentation and register. It is mandatory that the same user account is used for the registration and abstract submission if the presenter wishes to register before receiving notice of acceptance/rejection. If different accounts are used, we cannot ensure the link between the registration and abstract and guarantee the inclusion of the abstract.

Submission of the abstract constitutes the authors’ consent to publication (e.g. in the European Psychiatry Abstract e-Supplement, the website, congress programmes and other promotions, etc.).

Should the abstract be selected for oral presentation, the presenting author, on behalf of all authors, may have to sign an agreement to grant EPA the right to record the entire presentation (audio and slide) and subsequently use it for educational purposes (with or without a fee).

Abstracts not adhering to these guidelines will be rejected. If you do not agree with any of these rules, you should not submit an abstract. The final decision about acceptance of an abstract will be taken by the Scientific Programme Committee.

Abstract withdrawal

The EPA reserves the right to withdraw any abstracts that do not meet the scientific standards of the association at any point before or after acceptance and subsequent publication in the European Psychiatry Abstract e-Supplement.

If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to epa.abs@mci-group.com before 31 January 2024.

Important Dates

Regular Registrations: Now open
Deadline: 20 March 2024, 23:59 CET